China approves its first homegrown COVID drug
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
On Wednesday, a piece of good news emerged on the COVID-fighting front:
China’s drug regulator (NMPA) granted emergency approval of a COVID-19 treatment drug co-developed by Brii Biosciences, Tsinghua University, and the Third People’s Hospital of Shenzhen.
We’ll spare you the technical detai...